Margery Rothenberg

Margery Rothenberg brings more than 25 years of experience in medical marketing, with deep expertise spanning strategic planning, brand development, customer and market insight, digital and social media, demand generation, and the commercialization of technology and AI-driven products. Her career encompasses both large enterprises and emerging companies across diagnostics, pharmaceutical services, and medical data.

Margery has held senior marketing roles at IBM Watson Health, Merck, Diaceutics, Biovica, Chembio Diagnostics, MetPath (the predecessor to Quest Diagnostics), Neuromedical Systems, and CROs including Covance and MDS Pharma Services. At IBM Watson Health, she served as Global Product Marketing Leader for an AI-driven data product supporting pharmaceutical market access strategy. At Neuromedical Systems, she led the global launch of the PAPNET cytological screening system, earning a nomination for Marketer of the Year from the College of American Pathologists. Most recently, at Mauna Kea Technologies, she directed product development and marketing for the AI layer of the company's in-vivo cellular imaging platform and was awarded a design patent for the user interface.

At AdvisoryDx, Margery works with clients to articulate the clinical and scientific differentiation of their products and translates that into strategic marketing plans that connect meaningfully with target audiences. Her approach pairs rigorous strategic thinking with creative, cost-effective execution across branding, messaging, and multichannel tactics through digital, personal, and print channels.